View Ventures
Venture capitalDallas · Pre-Seed–Series A · 1 people tracked
Also known as VV MANAGEMENT LLC
Find your way into View Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Adam Kadlec to introduce you to Carter Meyer
You →Adam · together at Rivermark →Carter
Sign up to find every way you can get introduced to View Ventures
- Your email: who you already know at View Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the View Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
View Ventures invests in earlier-stage medical and health technology companies, applying a refined and tested investment philosophy. The firm typically takes board seats at its portfolio companies, reflecting a hands-on approach to supporting the development of life science and medical device businesses. Its focus areas draw on the founder's extensive background in life science investment funds and prior board roles at medical technology companies.
Source: firm website, verified Sep 29, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 6 of 6 portfolio companiesHealthtech ×6Medical Devices ×6Biotech ×1Gaming ×1Hardware ×1Marketplaces ×1
HQs:United States×5
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12018 · 12 dated
Brius (Brava) makes orthodontic teeth-straightening technology using its Independent Movers system, which it integrates with orthodontic practices.
HardwareHealthtechMedical Devices
Mehdi Peikar(Founder)in
Co-investorsCheyenne VenturesEvolution VC PartnersSand Hill AngelsShangBay Capital LLCTech Wildcatters
Euphrates Vascular develops the Pulse NanoMED System, a nanoscale interventional medical device that uses magnetically guided iron-oxide nanoparticles to reach and disrupt distal vascular occlusions beyond the reach of wires and catheters.
BiotechHealthtechMedical DevicesSt. Louis, US
Troy Long(Executive Officer)Jeffrey Blair(Director)Tim Blair(Executive Officer)inEric Moessinger(Director)Robert Mitchell(Director)Thomas Hillman(Director)
Co-investorsMissouri Technology CorporationOSF Ventures+ND CapitalCultivation Capital
Online138 is an Indonesian platform offering World Cup-themed gaming experiences and a skills marketplace (SkillConnect) connecting users with local tutors, designers, tradespeople, and service providers.
GamingHealthtechMarketplacesMedical DevicesSan Francisco, US
Austin Walker(Founder/CEO)inAl Chin(Founder)inTom Kramer(Founder)inThomas Harold Pierce(Executive Officer, Promoter)
Co-investorsHemisphere Ventures LLCPallasite VenturesY CombinatorAgrolimen VenturesAmzak HealthAvlok Capital+10 more
Rivermark Medical develops FloStent, a first-line device for treating benign prostatic hyperplasia (BPH) that is delivered during routine outpatient cystoscopy for urology practices and their patients.
HealthtechMedical DevicesMilwaukee, US
Anand Doraiswamy(Executive Officer, Director)Adam Kadlec(Co-founder)in
BoardScott Button(Director)Carter Meyer(Director)Matthew Ercolani(Director)Josh Baltzell(Director)
Co-investorsAndera Partners
Spirair develops minimally invasive, cartilage-preserving ENT (ear, nose, and throat) medical devices, including implants for correcting nasal septal deviation and supporting nasal passages after sinus surgery.
HealthtechMedical DevicesSouth San Francisco, US
Ben Bishop(Executive Officer, Director)inJames Kintzing(Executive Officer, Director)
BoardRob Binney(Director)Carter Meyer(Director)Kate Garrett(Director)in
Co-investors1809 CapitalSonder Capital
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.
HealthtechMedical DevicesSanta Cruz, US
Co-investorsCorewell Health VenturesSanta Cruz VentureBioStar CapitalCadence Healthcare VenturesS3 Ventures
Portfolio news
latest coverage across their companiesRivermark · trysignalbase.com · May 14, 2026
Frequently asked questions
- How many investments has View Ventures made?
- View Ventures has 6 tracked investments, including 1 dated in the last 24 months.
- What stage does View Ventures invest at?
- View Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does View Ventures focus on?
- View Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is View Ventures located?
- View Ventures is headquartered in Dallas, US.
- Who does View Ventures co-invest with?
- View Ventures most often shares deals with 1809 Capital, Cheyenne Ventures, Evolution VC Partners, among 12 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.



























.jpeg)
